Login To Trade  |  About IIFL
  • NIFTY  8421.8  46.75 0.56%
  • SENSEX 27705.35  141.92 0.51%
Farmax India Ltd

BSE: 590094 | NSE: FARMAXIND ISIN: INE890I01035
Market Cap: [Rs.Cr.] 12.82 Face Value: [Rs.] 1
Industry: Food - Processing - Indian

Watchlist +
Board Meet
  • 28-May-15

    • Farmax India Ltd has informed BSE that a meeting of Board of Director of the Company will be held on May 28, 2015, inter alia, to consider and approve the following: 1. Annual Financial Results for the 4th quarter and financial year ended March 31, 2015. In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of May 20, 2015 till day of May 30, 2015 (both days inclusive). Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, has considered and approved the following: 1. Pursuant to Regulation 8 of the SEBl (Prohibition of Insider Trading) Regulations, 2015, The Company has formulated Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information ('Code'). 2. Pursuant Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has formulated and adopted Code of Conduct for Prevention of Insider Trading for its employees and other connected persons, to regulate, monitor and report trading by the employees and other connected persons. 3. Secretarial Standard issued by the Institute of Company Secretaries of India. (As per BSE Announcement Dated on 28.05.2015)

  • 10-Mar-15

    • Farmax India Ltd has informed BSE that the Board of Directors of the Company in their meeting held on March 09, 2015, approved the following: The Board Meeting has been adjourned to March 10, 2015 at 10:00 A.M. to consider the allotment of balance 7,11,08,694 equity shares. Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2015, inter alia, has approved the following: - Allotment of 2,09,30,015 equity shares to promoters and others on preferential basis at an issue price of Rs. 1.32/- per share. (As Per BSE Announcement Dated on 10.03.2015)

  • 09-Mar-15

    • Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 05, 2015, approved the following: 1. The Board Meeting has been adjourned to March 06, 2015 at 10:00 A.M to consider the allotment of balance 8,61,37,121 equity shares. Farmax India Ltd has informed BSE that the Board of Directors of the Company in their meeting held on March 06, 2015, approved the following: 1. Allotment of 1,44,64,393 equity shares to promoters and others on preferential basis at an issue price of Rs. 1.32/- per share. 2. The Board Meeting has been adjourned to March 09, 2015 at 10:00 A.M to consider the allotment of balance 7,16,72,728 equity shares. (As Per BSE Announcement Dated on 07.03.2015)

  • 05-Mar-15

    • Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 04, 2015, inter alia, to consider and approve the following: - Allotment of Preferential Shares. Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 04, 2015, has considered and approved the following: - Allotment of equity shares on preferential basis. Further the meeting is adjourned to consider allotment of equity shares on preferential basis in proportion to the receipt of money. (As Per BSE Announcement Dated on 04.03.2015) Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 05, 2015, to consider and approve the following: - Allotment of Preferential Shares. (As Per BSE Announcement Dated on 04.03.2015) Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 05, 2015, approved the following: 1. Allotment of 1,38,62,878 equity shares to promoters and others on preferential basis at an issue price of Rs. 1.32/- per share. 2. The Board Meeting has been adjourned to March 06, 2015 at 10:00 A.M to consider the allotment of balance 8,61,37,121 equity shares. (As per BSE Announcement Dated on 05.03.2015)

  • 12-Dec-14

    • Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 12, 2014, inter alia, to consider and approve the following: 1. Considering the further issue of Equity shares and Warrants on preferential Basis to the Promoters and Non Promoters of the Company. Farmax India Ltd has informed BSE regarding Outcome of Board Meeting held on December 12, 2014. (As Per BSE Announcement Dated on 12.12.2014) Farmax India Limited has informed the Exchange that at the Board Meeting of the Company held on December 12, 2014 the following were considered and approved: (1) Increase Authorized Capital of the Company from Rs. 50 crores to 100 crores, subject to approval of members and consequently amend the required clauses of Memorandum of Association and Article of Association of the Company. (2) Raise Money by issuing shares on preferential basis subject to approval of shareholders. (3) To Convene the Extra Ordinary General Meeting on January 24, 2014. (As Per NSE Bulletin Date on 15.12.2014) Farmax India Ltd has now informed BSE that there was a typographical error in the outcome of Board meeting given on December 12, 2014. In the point no. 3 the EGM date was given as January 24, 2014 instead of January 24, 2015. (As Per BSE Announcement dated on 18/12/2014)

AGM
  • 30-Sep-14

    • Farmax India Ltd has informed BSE that the 19th Annual General Meeting (AGM) of the Company was held on September 30, 2014. Farmax India Ltd has informed BSE regarding the details of Voting results at the 19th Annual General Meeting (AGM) of the Company held on September 30, 2014, under Clause 35A. (As Per BSE Announcement dated on 01/10/2014)

  • 29-Jul-13

    • Farmax India Ltd has informed BSE that the 18th Annual General Meeting (AGM) of the Company was held on July 29, 2013.

  • 29-Sep-12

    • Farmax India Ltd has informed BSE that the 17th Annual General Meeting (AGM) of the Company was held on September 29, 2012.

  • 28-Oct-11

    • AGM 28/10/2011 Farmax India Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on October 28, 2011, inter alia, have transacted the following: 1. Shareholders adopted the Directors' Report, the Audited Profit and Loss Account, the Balance Sheet and Cash Flow statement as at March 31, 2011. 2. Mr. A V Ramaraju who retired by rotation and being eligible, offered himself for re-appointment was re-appointed. 3. M/s. K Prahalda Rao & Co. are appointed as Statutory Auditors of the company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company. 4. Appointment of Mr. Omkareshwar Ganganboina as a Director of the Company. (As Per BSE Announcement Website dated on 28.10.2011)

  • 09-Dec-10

    • AGM 09/12/2010 Farmax India Ltd has informed BSE that the following items of business have been considered and approved by the Shareholders in the 15th Annual General Meeting (AGM) of the Company held on December 09, 2010: 1. Approval of Audited Balance Sheet as at March 31, 2010 and Profit and Loss Account for the period ended as on that date, together with the report of the Board of Directors' and Auditor's thereon. 2. Appointment of Mrs. P. Hymavathi, who retires by rotation as Director. 3. Appointment of Mr. I. Srinivasa Raju, who retires by rotation as Director. 4. Re-appointment of M/s. K. Prahlada Rao & Co., Chartered Accountants as Statutory Auditors of the Company. 5. Alteration of Articles of Association. (As Per BSE Announcement Website dated on 10.12.2010)

EGM
  • 24-Jan-15

    • Farmax India Ltd has informed BSE that an Extra-Ordinary General Meeting (EGM) of the Company will be held on January 24, 2015. Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on January 24, 2015. (As Per BSE Announcement dated on 24/01/2015) Farmax India Ltd has submitted to BSE a copy of Revised Outcome of Extra Ordinary General Meeting (EGM) of the Company held on January 24, 2015. (As Per BSE Announcement Dated on 27.01.2015) Farmax India Limited has informed the Exchange that at the Extra-ordinary General Meeting of the Company held on January 24, 2015, the following items were considered and duly approved by the shareholders of the Company. 1) Increase in Authorized Share Capital of the Company. 2) Issue of equity shares to promoters and others on preferential basis. A copy of the consolidated report on e-votng and poll is enclosed. (Clause 35A of the Listing Agreement) (As Per NSE Bulletin Date on 27.01.2015)

  • 08-May-13

    • Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 08, 2013, has approved and considered the following : 1. To lease out the factory premises as per section 293 (1) (a) of the Companies Act, 1956. 2. Appointment of Bhaskara Rao & Associates as Statutory Auditors of the Company for the Financial Year 2012-13. 3. To hold Extra-Ordinary general Meeting on May 08, 2013 to take shareholders approval for item nos. 1 & 2 above. Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 08, 2013. (As per BSE Announcement Dated on 16.04.2013) Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 08, 2013. (As Per BSE Announcement Dated on 08.05.2013)

  • 19-Dec-11

    • Farmax India Ltd has informed BSE hat a meeting of the Board of Directors of the Company will be held on February 17, 2012 to review the process or progress of Preferential Allotment initiated in terms of special resolution passed in the EGM held on December 19, 2011.

  • 01-Jan-10

    • Farmax Retail (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has considered and approved the following: 1. Increase of Authorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. 4. Convening EGM of the shareholders on January 01, 2010 for the above matters. Farmax Retail (India) Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on January 01, 2010.inter alia, to transact the following items of business: 1. Increase of Authorized Share Capital: - To increase the Authorized Share Capital of the Company from Rs. 14,00,00,000/- (Rupees Fourteen Crores Only) divided into 1,40,00,000 (One Crore Forty Lakhs) equity shares of Rs. 10/- (Rupees Ten Only) each to Rs. 50,00,00,000/- (Rupees Fifty Crores Only) divided into 5,00,00,000 (Five Crores) equity shares of Rs. 10/- (Rupees Ten Only) each, ranking pari passu with the existing equity shares & consequential amendment in the Memorandum of Association of the Company. 2. Sub-division of the Face Value of Equity Shares: - For sub-division of each of the existing issued equity shares of Rs. 10/- (Rupees Ten Only) each in the issued, subscribed and paid-up capital of the Company into 2 (Two) equity shares of the face value of Rs. 5/- (Rupees Five Only) each fully paid up consequential amendment in the Memorandum and Articles of Association pertaining to the Share Capital of the Company be accordingly altered. 3. To raise monies on preferential basis: - To offer, issue and allot (including with provisions for reservation on firm and / or competitive basis, of such part of issue and for such categories of persons including employees of the Company as may be permitted) either in India or in the course of international offering(s) in one or more foreign markers, such number of Equity Shares with or without a green shoe option. Global Depository Receipts (GDRs), in registered or bearer form, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (as defined by the SEBI (DIP) Guidelines, 2000) pursuant to a Qualified Institutions Placements, as provided under Chapter XIIIA of the SEBI DIP Guidelines (QIP) and / or securities with or without detachable warrants with right exercisable by the warrant holders to convert or subscribe to Equity Shares (all of which are hereinafter collectively referred to as Securities) or any combination of Securities, in one or more tranches, whether rupee denominated or denominated in foreign currency, to any eligible person, including foreign / resident invertors (whether institutions, incorporated bodies, mutual funds, individuals or otherwise), Foreign Institutional Investors, Indian and / or Multilateral Financial Institutions, Mutual Funds, Non-Resident Indians, stabilizing agents, and / or any other categories of investors, whether they be holders of shares of the Company or not (collectively called the Investors) through public issue(s) of prospectus in India or outside India, a qualified institutional placement, a rights offering, private placements(s) in India or outside India, or a combination thereof at such time or times, at such price or prices, at a discount or premium to market price or prices in such manner and on such terms and conditions as may be deemed appropriate by the Board at its absolute discretion including the discretion to determine the categories of Investors to whom the offer, issue and allotment shall be made to the exclusion of all other categories of Investors at the time of such offer, issue and allotment considering the prevailing market conditions and other relevant factors and wherever necessary in consultation with Lead Managers, up to an amount not exceeding Rs. 500 Crores (Rupees Five Hundred Crores Only) either in foreign currency or Indian Rupees inclusive of such premium as may be determined by the Board, in any convertible foreign currency, as the Board at its absolute discretion may deem fit and appropriate, subject to necessary provisions & approvals. (As Per BSE Announcement Dated on 30/12/2009) Farmax Retail (India) Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 01, 2010, inter alia, have approved the following: 1. Increase ofAuthorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. (As Per BSE Announcement Dated on 04/01/2010)

Futures & Options Quote
Future Data Not present
Key Information

Key Executives:

M Srinivasa Reddy , Chairman & Managing Director

A V Rama Raju , Director

Priyanka Palacarla , Director

Sudheer Reddy , Director


Company Head Office / Quarters:

Survey No 658 Bowrampet Villag,
Qutubullapur Mandal,
Ranga Reddy,
Andhra Pradesh-501505
Phone : Andhra Pradesh- / Andhra Pradesh-
Fax : Andhra Pradesh- / Andhra Pradesh-
E-mail :
Web :

Registrars:

Big Share Services Pvt Ltd
3rd Flr 306 Rightwin,Amrutha Ville,Somajiguda,Hyderabad-500082

 
Fund Holding
Scheme Name No. of Shares
 
Calendar
Mon Tue Wed Thu Fri Sat Sun
22 23 24 25 26 27 28